Abstract
The levels of tumor markers in cystic fluid and serum were measured in six patients with benign biliary cyst of the liver. AFP in the cystic fluid was lower than the upper normal limit for serum in all cases, and CEA in the cystic fluid was higher than the upper normal limit for serum in one of the six cases. CA19-9, DU-PAN 2, and SPAN 1 in cystic fluid were much higher than the upper normal limit for serum in all cases (more than 100-fold for CA19-9, twofold for DU-PAN 2, and ninefold for SPAN 1). CA19-9, DU-PAN 2, and SPAN 1 in cystic fluid were significantly higher than the levels in the corresponding serum. Positive immunohistochemical staining against CA19-9, DU-PAN 2, and SPAN 1 was observed in the cytoplasm of the epithelial cells of the cyst wall. These results suggested that the high concentrations of CA19-9, DU-PAN 2, and SPAN 1 in the cystic fluid were due to secretion from the epithelial cells in the benign biliary cysts.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Nishida K, Shiga K, Kato K, Kunihiro K, Fujii T, Tomii T, Yamamoto H, Yamane E, Nishioka B, Yoshikawa T, Kondo M: Two cases of pancreatic cystadenocarcinoma with elevated CA19-9 levels in the cystic fluid in comparison with two cases of pancreatic cystadenoma. Hepatogastroenterology 36:442–447, 1989
Tatsuta M, Iishi H, Ichii M, Noguchi S, Yamamoto R, Yamamura H, Okuda S: Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas. Cancer 57:1836–1839, 1986
Pinto MM, Bernstein LH, Brogan DA, Parikh F, Lavy G: Measurement of CA125, carcinoembryonic antigen, and alpha-fetoprotein in ovarian cyst fluid: Diagnostic adjunct to cytology. Diagn Cytopathol 6:160–163, 1990
Korobkin M, Stephens DH, Lee JKT, Stanley R, Fishman EK, Francis IR, Alpem MB, Rynties M: Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. Am J Roentgenol 153:507–511, 1989
Pinto MM, Kaye AD: Fine needle aspiration of cystic liver lesions. Cytologic examination and carcinoembryonic antigen assay of cyst contents. Acta Cytol 33:852–856, 1989
Del Villano BC, Brenna S, Broock P, Bucher C, Liu V, McClure M, Rake B, Space S, Westrick B, Schoemaker H, Zurawski Jr VR: Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA19-9. Clin Chem 29:549–552, 1983
Mahvi DM, Meyers WC, Bast RC, Seigler HF, Metzgar RS: Therapeutic efficacy as defined by a serodiagnostic test utilizing a monoclonal antibody. Ann Surg 202:440–447, 1985
Umeyama K, Takeuchi T, Chung YS, Satake K, Takebe T, Yachi A, Matsuno S, Fujiki T, Ozaki H, Morioka Y, Homma T, Kawa S, Miyazaki I, Sawabu N, Nakano S, Hayakawa T, Takagi H, Mizumoto R, Manabe T, Kannagi R, Mori T, Tatsuta M, Saito Y, Abe M, Ichiya Y, Oshiumi Y, Tsuchiya R, Yamane N, Hirota Y, Kim YS: Clinical evaluation of measurement of pancreatic cancer associated antigen, SPAN 1. J Jpn Panc Soc 3:528–539, 1988
Snedecor GW, Cochran WG: Statistical Methods. Ames, Iowa: The Iowa State University Press, 1967, pp 104–106
Hsu SM, Raine L, Fanger H: Use of avidin-biotinperoxidase complex (ABC) in immunoperoxidase technique: A comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 29:577–580, 1981
Neville AM, Laurence DJR: Report of the workshop on the carcinoembryonic antigen (CEA): The present position and proposals for future investigation. Int J Cancer 14:1–18, 1974
Akiyama H, Yamamoto M, Sumiyoshi H, Tahara E, Iwamori S: Carcinoembryonic antigen (CEA) in gallbladder bile and mucosa in cholecystolithiasis. Acta Chir Scand 152:509–513, 1986
Tomioka T, Tsuchiya R, Harada N, Tsunoda T, Matsuo T: Cystadenoma and cystadenocarcinoma of the liver: Localization of carcinoembryonic antigen. Jpn J Surg 16:62–67, 1986
Koprowski H, Stephewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P: Colorectal carcinoma antigens detected by hybridoma antibodies. Somat Cell Genet 5:957–972, 1979
Metzgar RS, Gaillard MT, Levin ST, Tuck FL, Bossen EH, Borowitz MJ: Antigens of human, pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Cancer Res 42:601–608, 1982
Chung YS, Ho JJL, Kim YS, Tanaka H, Nakata B, Hiura A, Motoyoshi H, Satake K, Umeyama K: The detection of human pancreatic cancer-associated antigen in the serum of cancer patients. Cancer 60:1636–1643, 1987
Gupta MK, Arciaga R, Bocci L, Tubbs R, Bukowski R, Deodhar SD: Measurement of a monoclonal-antibodydefined antigen (CA19-9) in the sera of patients with malignant and nonmalignant diseases. Cancer 56:277–283, 1985
Farini R, Fabris C, Bonvicini P, Piccoli A, Del Favero G, Venturini R, Panicci A, Naccarato R: CA19-9 in the differential diagnosis between pancreatic cancer and chronic pancreatitis. Eur J Cancer Clin Oncol 21:429–432, 1985
Metzgar RS, Rodriguetz N, Finn OJ, Lan MS, Daasch VN, Fernsten PD, Meyers WC, Sindelar WF, Sandler RS, Seigler HF: Detection of a pancreatic cancer associated antigen (DU-PAN 2 antigen) in serum and ascites of patients with adenocarcinoma. Proc Natl Acad Sci USA 81:5242–5246, 1984
Sawabu N, Toya D, Takemori Y, Hattori N, Fukui M: Measurement of a pancreatic cancer-associated antigen (DU-PAN 2) detected by a monoclonal antibody in sera of patients with digestive cancers. Int J Cancer 37:693–696, 1986
Chung YS, Satake K, Umeyama K, Kim YS: A new series of monoclonal antibodies against pancreatic cancer cells. J Jpn Surg Soc 88:89–95, 1987
Atkinson B, Erust C, Herlyn M, Steplewski Z, Sears HF, Koprowski H: Gastrointestinal cancer-associated antigen in immunoperoxidase assay. Cancer Res 42:4280–4283, 1983
Albert MB, Steinberg WM, Henry JP: Elevated serum levels of tumor marker CA19-9 in acute cholangitis. Dig Dis Sci 33:1223–1225, 1988
Borowitz MJ, Tuck FL, Sindelar WF, Fernsten PD, Metzgar RS: Monoclonal antibodies against human, pancreatic adenocarcinoma: Distribution of DU-PAN 2 antigen on glandular epithelia and adenocarcinomas. J Nat Cancer Inst 72:999–1003, 1984
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Iwase, K., Takenaka, H., Oshima, S. et al. Determination of tumor marker levels in cystic fluid of benign liver cysts. Digest Dis Sci 37, 1648–1654 (1992). https://doi.org/10.1007/BF01299853
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01299853